Noemi Panzera
L'aquila, 67100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 04, 2022
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis.
Journal: Arthritis research & therapy
Published: December 21, 2020
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.
Journal: Scientific reports
Published: March 31, 2020
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Journal: Arthritis research & therapy
Published: February 14, 2020
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling.
Journal: Scientific reports
Published: January 08, 2019
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Journal: Arthritis research & therapy
Published: June 06, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026